Skip to main content
Log in

Respiratory symptoms, lung function tests, airway responsiveness, and bronchoalveolar lymphocyte subsets in B-Chronic lymphocytic leukemia

  • Published:
Lung Aims and scope Submit manuscript

Abstract

A respiratory questionnaire was completed and spirometry, tests for lung volumes, diffusion capacity for CO, and methacholine bronchial challenge were performed in 24 outpatients with B-chronic lymphocytic leukemia (B-CLL), aged 44–79, presenting in different stages of their disease. In 10 patients, bronchoalveolar lavage (BAL) fluid was also obtained. Ten of twenty-four patients had symptoms consistent with chronic bronchitis, unrelated both to smoking history and to the clinical stage. Abnormal values (<2 SD) were found in 4 patients for total lung capacity (TLC), in 9 for vital capacity (VC), 8 for forced expiratory volume in 1 sec (FEV1), 11 for MEF50, 15 for MEF25 and in 7 for diffusing capacity for carbon monoxide. Seven of nineteen patients had PD20FEV1 at less than 1,600 μg of methacholine chloride. There was a significantly negative correlation between white blood cell count and VC (r = 0.41, P < 0.05). A positive correlation was found between PD20FEV1 and FEV1/VC (r = 0.61, P < 0.01). The mean and SEM for BAL cells/ml was 463 (71.8) × 103. No leukemic cells but a marked increase in T lymphocytes (32.5 ± 7.8%) were found in BAL fluid. There were significantly negative correlations between the number of BAL CD3+ T lymphocytes and PD20FEV1 (r = 0.61, P < 0.05), and between the number of BAL CD8+ T lymphocytes and PD20FEVJ1(r = 0.84, P < 0.01). In conclusion, patients with B-CLL have a high prevalence of respiratory symptoms, small airway dysfunction and CD8 “alveolitis” related to airway responsiveness; despite the well-known lung interstitial lymphocyte infiltration in B-CLL, leukemic cells are not found in BAL fluid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Thoracic Society Executive Committee (1978) Recommended standardized procedure 2.for pulmonary function testing. Am Rev Respir Dis 118(2):55–72

    Google Scholar 

  2. American Thoracic Society (1987) Single breath carbon monoxide diffusing capacity (transfer factor): recommendation for a standard technique. Am Rev Respir Dis 136:1299–1307

    Google Scholar 

  3. Araujo A, Alfarroba E, Costa M (1986) The role of monoclonal antibodies in the study of chronic inflammatory respiratory diseases induced by dust inhalation. Eur J Respir Dis 69 (Suppl 146):203–210

    Google Scholar 

  4. Bunch C (1987) Management of infection in’chronic lymphocytic leukemia. In: Gale RP, Rai KR (eds) Chronic lymphocytic leukemia: recent progress, future advance. Alan R. Liss, New York, pp 373–381

    Google Scholar 

  5. Caligaris-Cappio F, Janossy G (1985) Surface markers in chronic lymphoid leukemias of B-cell type. Semin Hematol 22:1–12

    PubMed  CAS  Google Scholar 

  6. Cerveril, Bruschi C, Zoia MC, Zanon P, Maccarini L, Grassi M, Rampulla C (1988) Distribution of bronchial nonspecific reactivity in the general population. Chest 93:26–30

    Article  Google Scholar 

  7. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townley RG (1975) Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 56:323–327

    Article  PubMed  CAS  Google Scholar 

  8. Chernoff A, Rymuza J, Lippmann ML (1984) Endobronchial lymphocytic infiltration: unusual manifestation of chronic lymphocytic leukemia. Am J Med 77:755–759

    Article  PubMed  CAS  Google Scholar 

  9. Cole SR, Myers TJ, Klatsky AU (1978) Pulmonary disease with chlorambucil therapy. Cancer 41:455–459

    Article  PubMed  CAS  Google Scholar 

  10. Copper A, White D, Matthay RA (1986) Drug-induced pulmonary diseases (part 1). Am Rev Respir Dis 133:321–340

    Google Scholar 

  11. Costabel U, Bross KJ, Marxen J, Matthys H (1984) T-lymphocytosis in bronchoalveolar lavage fluid of hypersensitivity pneumonitis. Changes in profile of T-cell subset during the course of disease. Chest 85:514–518

    Article  PubMed  CAS  Google Scholar 

  12. Costabel U, Teschler H, Guzman J (1992) Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 5:791–797

    PubMed  CAS  Google Scholar 

  13. Davis WB, Gadek JE (1987) Detection of pulmonary lymphoma by bronchoalveolar lavage. Chest 91:787–90

    Article  PubMed  CAS  Google Scholar 

  14. Ferris BG Jr (1987) Epidemiology standardization project. Am Rev Respir Dis 118(2): 1–88

    Google Scholar 

  15. Green RA, Nichols NJ (1959) Pulmonary involvement in leukemia. Am Rev Respir Dis 80:833–844

    Google Scholar 

  16. Green RA, Nichols NJ, King EJ (1959) Alveolar-capillary block due to leukemic infiltration of the lung. Am Rev Respir Dis 80:895–901

    Google Scholar 

  17. Guillon JM, Autron B, Denis M, Foret P, Plata F, Mayaud CM (1988) Human immunodeficiency virus-related lymphocytic alveolitis. Chest 94:1264–1270

    Article  PubMed  CAS  Google Scholar 

  18. Hansen MM (1973) Chronic lymphocytic leukemia: clinical studies based on 189 cases followed for a long time. Scand J Haematol (suppl) 18:1–286

    Google Scholar 

  19. Kelley J (1990) Cytokines of the lung. Am Rev Respir Dis 141:765–788

    PubMed  CAS  Google Scholar 

  20. Klech H, Pohl W (1989) Technical recommendation and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 2:561–585

    Google Scholar 

  21. Macklem PT, Permutt S (1979) The lung in the transition between health and disease. Lung biology in health and disease, vol 12. Marcel Dekker, New York and Basel

    Google Scholar 

  22. Martin II WJ (1992) Drug induced lung disease. In: Kelley WN (ed in chief) Textbook of internal medicine. J.B. Lippincott Co., New York, pp 1772–1776

    Google Scholar 

  23. McFadden ER Jr, Holmes B, De Groot WJ (1974) Small airway disease: an assessment of the tests of peripheral airway function. Am J Med 57:171–181

    Article  PubMed  Google Scholar 

  24. O’Byrne PM (1986) Airway inflammation and airway hyperresponsiveness. Chest 90:575–577

    Article  PubMed  Google Scholar 

  25. Quanjer PH (1983) Standardized lung function testing. Bull Eur Physiopath Respir 19 (suppl 5): 1–91

    Google Scholar 

  26. Rai KR, Sawitsky A, Chanana AD, Levy RN, Pasternack BS (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46:219–234

    PubMed  CAS  Google Scholar 

  27. Resnick ME, Berkowitz RD, Rodman T (1961) Diffuse interstitial leukemic infiltration of the lungs producing the alveolar-capillary block syndrome. Am J Med 31:149–153

    Article  PubMed  CAS  Google Scholar 

  28. Reynolds HY (1987) Bronchoalveolar lavage. Am Rev Respir Dis 135:250–263

    PubMed  CAS  Google Scholar 

  29. Ross JS, Ellmann L (1974) Leukemic infiltration of the lungs in the chemiotherapeutic era. Am J Clin Pathol 61:235–241

    PubMed  CAS  Google Scholar 

  30. Rozman C, Montserrat E, Vinolas N (1988) Serum immunoglobulins in B-chronic lynphocytic leukemia. Cancer 61:279–283

    Article  PubMed  CAS  Google Scholar 

  31. Tenholder MF, Hopper RG (1980) Pulmonary involvement in leukemia. Chest 78:468–473

    Article  PubMed  CAS  Google Scholar 

  32. Wallaertf B, Rossi GA, Sibille Y (1990) Collagen-vascular diseases. In: Klech H, Hutter C (eds) Clinical guidelines and indications for bronchoalveolar lavage. Eur Respir J 3:942-943

  33. Weynants P, Cordier JF, Chapuis Cellier C, Pages J, Loire R, Brune J (1985) Primary immuno-cytoma of the lung: the diagnostic value of bronchoalveolar lavage. Thorax 40:542–543

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rolla, G., Bucca, C., Chiampo, F. et al. Respiratory symptoms, lung function tests, airway responsiveness, and bronchoalveolar lymphocyte subsets in B-Chronic lymphocytic leukemia. Lung 171, 265–275 (1993). https://doi.org/10.1007/BF03215870

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03215870

Key words

Navigation